Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership
CUSIP: 74291D104
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
61
Shares (Excl. Options)
41,944,849
Price
$2.24
- Type / Class
- Equity / Class A Common Stock
- Symbol
- PROK on Nasdaq
- Shares outstanding
- 141,999,700
- Price per share
- $2.46
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 41,944,849
- Total reported value
- $93,956,490
- % of total 13F portfolios
- 0%
- Share change
- +8,493,675
- Value change
- +$18,974,610
- Number of holders
- 61
- Price from insider filings
- $2.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PROK - PROKIDNEY CORP. - Class A Common Stock is tracked under CUSIP 74291D104.
- 61 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 55 to 61 between Q3 2025 and Q4 2025.
- Reported value moved from $80,954,450 to $93,956,490.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 74291D104?
CUSIP 74291D104 identifies PROK - PROKIDNEY CORP. - Class A Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74291D104:
Significant Owners of PROKIDNEY CORP. - Class A Common Stock (PROK) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 6% | $19,510,759 | 8,519,982 | Morgan Stanley | 31 Dec 2025 |
As of 31 Dec 2025, 61 institutional investors reported holding 41,944,849 shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 30% of the company’s total 141,999,700 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PROKIDNEY CORP. - Class A Common Stock (PROK) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.7% | 12,341,266 | 0% | 0.69% | $27,644,436 |
| MORGAN STANLEY | 6.2% | 8,817,001 | +31% | 0% | $19,750,082 |
| Bleichroeder LP | 1.4% | 2,000,000 | 0% | 0.79% | $4,480,000 |
| Artia Global Partners LP | 1.3% | 1,838,411 | 0.66% | $4,118,041 | |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 1,834,536 | -6.2% | 0% | $4,109,361 |
| VANGUARD GROUP INC | 1.2% | 1,648,229 | +5.4% | 0% | $3,692,033 |
| Hennion & Walsh Asset Management, Inc. | 1.1% | 1,503,886 | +63% | 0.12% | $3,368,705 |
| BlackRock, Inc. | 0.99% | 1,404,167 | +9.9% | 0% | $3,145,334 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.84% | 1,197,530 | +9.2% | 0% | $2,683,540 |
| RENAISSANCE TECHNOLOGIES LLC | 0.63% | 895,705 | +579% | 0% | $2,006,379 |
| BANK OF AMERICA CORP /DE/ | 0.5% | 706,144 | +6.9% | 0% | $1,581,763 |
| GOLDMAN SACHS GROUP INC | 0.48% | 681,161 | +314% | 0% | $1,525,801 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.44% | 623,110 | -4.6% | 0% | $1,395,766 |
| MARSHALL WACE, LLP | 0.43% | 612,485 | +654% | 0% | $1,371,967 |
| Woodline Partners LP | 0.35% | 500,000 | 0% | $1,120,000 | |
| JANE STREET GROUP, LLC | 0.35% | 493,849 | +616% | 0% | $1,106,222 |
| STATE STREET CORP | 0.34% | 480,345 | +1.1% | 0% | $1,075,973 |
| TWO SIGMA INVESTMENTS, LP | 0.33% | 465,509 | +369% | 0% | $1,042,740 |
| MYDA Advisors LLC | 0.31% | 440,000 | -2.2% | 0.28% | $985,600 |
| UBS Group AG | 0.29% | 416,539 | -18% | 0% | $933,047 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 398,880 | +56% | 0% | $893,491 |
| CITADEL ADVISORS LLC | 0.26% | 371,797 | +7.8% | 0% | $832,825 |
| Squarepoint Ops LLC | 0.25% | 351,421 | +2% | 0% | $787,183 |
| Amundi | 0.19% | 272,242 | 0% | $609,822 | |
| NORTHERN TRUST CORP | 0.17% | 241,580 | +27% | 0% | $541,139 |